06 May UBS Report Names LifeNome as one of the Key Players in the Personalized Genomics Market
Posted at 09:00h
in Uncategorized
The UBS evidence lab, in its Genomcis 2.0 report, has identified LifeNome as one of the key players in the emerging personalized genomics market. Alongside with Ancestry.com, 23andMe and FamilyTreeDNA, LifeNome was one of the best known brands for individuals who had already done genetic testing.